Associations of self-esteem in people with epilepsy.

Epilepsy BehavJul 7, 2026 (epub)
Clinical ResearchNeurology

Eva Popoluska, Gbemisola Stella Ogunlade, Elizabeth Corker et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined factors associated with self-esteem in people with epilepsy (PWE) by analyzing 26 studies with a total of 3,405 participants. It identified that negative self-esteem correlates included stigma, anxiety, and depression, while positive correlates were knowledge about epilepsy, life satisfaction, and social support. Most studies were cross-sectional and of moderate quality.

Key findings

  • Negative self-esteem in PWE correlates with stigma, anxiety, and depression.
  • Positive self-esteem correlates include knowledge about epilepsy and life satisfaction.
  • Seizure frequency's impact on self-esteem showed mixed findings across studies.
  • Healthcare providers should implement holistic interventions to enhance self-esteem in PWE.

Why it matters

Understanding the factors influencing self-esteem in PWE is crucial for clinicians, as self-esteem is linked to various positive life outcomes. Addressing these factors can improve overall well-being and quality of life for patients.

Source

PubMed · PMID 42413256

Published in Epilepsy Behav. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.